microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass

Area of Science:

• Cardiovascular Surgery
• Molecular Biology
• Neonatal Medicine

Background:

• Systemic inflammation post-cardiopulmonary bypass (CPB) impacts neonatal outcomes.
• Mechanisms of CPB-induced inflammation in circulating leukocytes are not fully understood.
• MicroRNAs (miRNAs) are key regulators of cellular function and protein levels.

Purpose of the Study:

• To investigate microRNA (miRNA) expression changes in neonatal leukocytes during and after cardiopulmonary bypass (CPB).
• To identify specific miRNAs and their target pathways involved in CPB-associated inflammation.
• To gain deeper insight into the molecular mechanisms of systemic inflammation following CPB.

Main Methods:

• MicroRNA-sequencing of leukocytes from 5 neonatal patients undergoing CPB at 7 time points.
• Statistical analysis using generalized linear regression models with false discovery rate adjustment (P<0.05).
• Identification of miRNA gene targets using the TargetScan database and pathway enrichment analysis.

Main Results:

• Identified 54 differentially expressed miRNAs during and after CPB.
• miRNAs clustered into three groups based on expression patterns (increased, decreased, or delayed increase).
• Target genes of altered miRNAs are predicted to modulate inflammation and signal transduction pathways.

Conclusions:

• Unbiased miRNA profiling reveals significant changes in circulating leukocytes following CPB.
• These findings provide novel insights into the mechanisms of bypass-associated systemic inflammation.
• Data may aid in developing new treatments and biomarkers for CPB-related inflammation.